Literature DB >> 19673912

Headache attributed to intracranial tumours: a prospective cohort study.

L Valentinis1, F Tuniz, F Valent, M Mucchiut, D Little, M Skrap, P Bergonzi, G Zanchin.   

Abstract

Between January 2007 and March 2008, we prospectively studied all patients operated on for intracranial tumours in our Department of Neurosurgery. Preoperatively, all patients were interviewed by a neurologist to collect headache characteristics. Measurements of tumour and oedema volume were made using dedicated software for magnetic resonance imaging studies. Tumour histopathology was established by histological examination postoperatively. If headache improved postoperatively, a diagnosis of 'headache attributed to intracranial neoplasm' was made, according to the 2004 International Classification of Headache Disorders (ICHD-II). A multivariate logistic regression model was used to evaluate the association of headache with potential risk factors. We studied 206 subjects. The prevalence of tumour headache was 47.6%. Intracranial tumour headache was non-specific and in most cases could not be classified by current ICHD-II diagnostic criteria for primary headache syndromes. Its prevalence varied depending on volume, location and type of tumour, as well as on the patient's previous headache history.

Entities:  

Mesh:

Year:  2010        PMID: 19673912     DOI: 10.1111/j.1468-2982.2009.01970.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  16 in total

Review 1.  Tension-type headache mimics.

Authors:  Sara C Crystal; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2011-12

Review 2.  [Headaches].

Authors:  M Michl; G M Michl
Journal:  Internist (Berl)       Date:  2017-09       Impact factor: 0.743

Review 3.  It IS a tumor -- current review of headache and brain tumor.

Authors:  Kevin Kahn; Alan Finkel
Journal:  Curr Pain Headache Rep       Date:  2014-06

4.  [Impact of anamnestic information and neurological deficits on the detection rate of secondary headaches].

Authors:  P B Sporns; L Hälker; W Heindel; T Niederstadt; T Allkemper; R Dziewas; W Schwindt
Journal:  Radiologe       Date:  2018-09       Impact factor: 0.635

5.  Isolated headache is not a reliable indicator for brain cancer: the 2-week wait pathway for suspected CNS malignancies.

Authors:  Bryan Ceronie; Thomas Hart; Daniel Belete; Lucille Ramani; Anish Bahra
Journal:  Clin Med (Lond)       Date:  2021-11       Impact factor: 2.659

Review 6.  Neuro-oncology and supportive care: the role of the neurologist.

Authors:  Natalie E Stec; Tobias Walbert
Journal:  Neurol Sci       Date:  2022-01-05       Impact factor: 3.830

7.  Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry.

Authors:  Birthe Krogh Rasmussen; Steinbjørn Hansen; René J Laursen; Michael Kosteljanetz; Henrik Schultz; Bente Mertz Nørgård; Rikke Guldberg; Kim Oren Gradel
Journal:  J Neurooncol       Date:  2017-08-31       Impact factor: 4.130

8.  Avoiding misdiagnosis in patients with neurological emergencies.

Authors:  Jennifer V Pope; Jonathan A Edlow
Journal:  Emerg Med Int       Date:  2012-07-25       Impact factor: 1.112

Review 9.  Secondary headaches: secondary or still primary?

Authors:  Christoph J Schankin; Andreas Straube
Journal:  J Headache Pain       Date:  2012-04-01       Impact factor: 7.277

10.  Nomogram for Postoperative Headache in Adult Patients Undergoing Elective Cardiac Surgery.

Authors:  Dashuai Wang; Sheng Le; Jia Wu; Fei Xie; Ximei Li; Hongfei Wang; Anchen Zhang; Xinling Du; Xiaofan Huang
Journal:  J Am Heart Assoc       Date:  2022-04-12       Impact factor: 6.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.